Refocus Group, Inc. (RFCS) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Dallas, TX, United States. El CEO actual es J. Michael Judy.
RFCS tiene fecha de IPO 2003-03-07, 4 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $25.00.
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
